Evidence map›Paper›PMID 41172302›Full record

SynthesisJMIR cancer2025

Experiences of Cancer-Related Cognitive Impairment Across Cancer Types: Qualitative Systematic Review.

Maryam Ibrar, Harleen Kaur Rai, Ashleigh Main, Haruno McCartney, Mario A Parra, Roma Maguire

Abstract readSystematic Review
In one paragraph

Synthesis in JMIR cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryam IbrarUniversity of Strathclyde, Glasgow, United Kingdom.ORCID 0009-0004-3633-5563
Harleen Kaur RaiTrimbos Institute, Utrecht, The Netherlands.ORCID 0000-0002-8121-6094
Ashleigh MainUniversity of Strathclyde, Glasgow, United Kingdom.ORCID 0009-0000-4639-7486
Haruno McCartneyUniversity of Strathclyde, Glasgow, United Kingdom.ORCID 0009-0006-1740-3078
Mario A ParraUniversity of Strathclyde, Glasgow, United Kingdom.ORCID 0000-0002-2412-648X
Roma MaguireUniversity of Strathclyde, Glasgow, United Kingdom.ORCID 0000-0001-7935-3447

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer-related cognitive impairment (CRCI) is frequently reported during cancer treatment, with 35% of patients experiencing cognitive issues even after treatment completion. Commonly reported impairments include difficulties with memory, attention, executive function, and processing speed, which often reduce daily functioning and quality of life (QoL). Despite its prevalence, CRCI remains underresearched across various cancer types, limiting understanding of the patient experience.

objectiveThis study aims to synthesize the qualitative evidence regarding the lived experience of CRCI across cancer types. It seeks to do so by exploring how commonly CRCI is subjectively experienced among cancer populations. It also aims to explore the cognitive domains perceived as most affected and the impact on QoL and functional ability.

methodsWe conducted a qualitative systematic review using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. A comprehensive search across PubMed, APA PsycInfo, CINAHL, and Scopus for studies published from 2013 through July 2025 was performed. Articles addressing the experience of CRCI using qualitative or mixed methods were included. Two independent reviewers screened titles, abstracts, and full texts, with a third reviewer resolving conflicts during the inclusion process. Two reviewers piloted the data extraction process by discussing and selecting 10% of the studies. The Critical Appraisal Skills Programme checklist was used for data extraction and quality assessment. Data were analyzed using thematic analysis.

resultsThe database search identified 11,269 papers; 51 were included for analysis. Breast cancer was the most represented cancer type (n=32). The analysis revealed 4 themes. "Cognitive challenges" explores the impacted cognitive domains such as memory, concentration, executive functions, language, and processing speed; "navigating employment" discusses challenges associated with return to work, support, and disclosure; "emotional, behavioral, and psychological impacts" explores emotional and psychological responses; and "support systems" emphasizes the role of social and health care support. CRCI negatively affects QoL and functional ability, and there is lack of understanding and resources in place to manage its effects.

conclusionsThis qualitative systematic review highlights the significant disruption of CRCI in daily life, stressing the need for increased awareness, standardized screening, and further research into digital interventions. Improved management of CRCI can support survivors of cancer in reintegrating into their daily lives and employment. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/56888.

Indexed as

Cognitive DysfunctionNeoplasmsHumansQualitative ResearchQuality of Lifecancer-related cognitive impairmentcancer survivorshipchemobrainchemotherapy late effectscognitive dysfunctionCRCIreturn to work

Identifiers

PMID41172302
PMCPMC12619018

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.